184 related articles for article (PubMed ID: 7903312)
1. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
Bertherat J; Chanson P; Dewailly D; Dupuy M; Jaquet P; Peillon F; Epelbaum J
J Clin Endocrinol Metab; 1993 Dec; 77(6):1577-83. PubMed ID: 7903312
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
[TBL] [Abstract][Full Text] [Related]
3. Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone- and alpha-subunit-secreting tumors from acromegalic patients responsive to octreotide.
Bertherat J; Turpin G; Rauch C; Li JY; Epelbaum J; Sassolas G; Schaison G
J Clin Endocrinol Metab; 1994 Nov; 79(5):1457-64. PubMed ID: 7962343
[TBL] [Abstract][Full Text] [Related]
4. Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog.
Bertherat J; Chanson P; Dewailly D; Enjalbert A; Jaquet P; Kordon C; Peillon F; Timsit J; Epelbaum J
Horm Res; 1992; 38(1-2):94-9. PubMed ID: 1306525
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.
Moyse E; Le Dafniet M; Epelbaum J; Pagesy P; Peillon F; Kordon C; Enjalbert A
J Clin Endocrinol Metab; 1985 Jul; 61(1):98-103. PubMed ID: 2860120
[TBL] [Abstract][Full Text] [Related]
6. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status.
Reubi JC; Landolt AM
J Clin Endocrinol Metab; 1989 Apr; 68(4):844-50. PubMed ID: 2537844
[TBL] [Abstract][Full Text] [Related]
7. Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients.
Ikuyama S; Nawata H; Kato K; Ibayashi H; Nakagaki H
J Clin Endocrinol Metab; 1986 Apr; 62(4):729-33. PubMed ID: 2869049
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.
Tulipano G; Bonfanti C; Milani G; Billeci B; Bollati A; Cozzi R; Maira G; Murphy WA; Poiesi C; Turazzi S; Giustina A
Neuroendocrinology; 2001 May; 73(5):344-51. PubMed ID: 11399907
[TBL] [Abstract][Full Text] [Related]
9. Specific somatostatin receptors on human pituitary adenoma cell membranes.
Ikuyama S; Nawata H; Kato K; Karashima T; Ibayashi H; Nakagaki H
J Clin Endocrinol Metab; 1985 Oct; 61(4):666-71. PubMed ID: 2863281
[TBL] [Abstract][Full Text] [Related]
10. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract][Full Text] [Related]
11. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
Kelijman M; Williams TC; Downs TR; Frohman LA
J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
[TBL] [Abstract][Full Text] [Related]
13. Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas.
Saveanu A; Gunz G; Dufour H; Caron P; Fina F; Ouafik L; Culler MD; Moreau JP; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 2001 Jan; 86(1):140-5. PubMed ID: 11231991
[TBL] [Abstract][Full Text] [Related]
14. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090).
Faglia G; Bazzoni N; Spada A; Arosio M; Ambrosi B; Spinelli F; Sara R; Bonino C; Lunghi F
J Clin Endocrinol Metab; 1991 Oct; 73(4):850-6. PubMed ID: 1653785
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of basal and corticotropin-releasing hormone-stimulated adenylate cyclase activity and cytosolic Ca2+ levels by somatostatin in human corticotropin-secreting pituitary adenomas.
Spada A; Reza-Elahi F; Lania A; Bassetti M; Atti E
J Clin Endocrinol Metab; 1990 May; 70(5):1262-8. PubMed ID: 1970828
[TBL] [Abstract][Full Text] [Related]
16. Some changes of receptor and postreceptor signal transduction regulated by somatostatin in pituitary hGH-secreting adenomas.
Deng J; Shi Y; Yin J
Chin Med J (Engl); 1997 Sep; 110(9):678-81. PubMed ID: 9642323
[TBL] [Abstract][Full Text] [Related]
17. Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5?
Pisarek H; Pawlikowski M; Kunert-Radek J; Winczyk K
Endokrynol Pol; 2010; 61(2):178-81. PubMed ID: 20464704
[TBL] [Abstract][Full Text] [Related]
18. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumors.
Mouhieddine OE; Levy L; Benlot C; Peillon F; Joubert D
J Clin Endocrinol Metab; 1995 May; 80(5):1691-5. PubMed ID: 7745020
[TBL] [Abstract][Full Text] [Related]
20. BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.
Jaquet P; Gunz G; Saveanu A; Barlier A; Dufour H; Taylor J; Dong J; Kim S; Moreau JP; Culler MD
J Endocrinol Invest; 2005; 28(11 Suppl International):21-7. PubMed ID: 16625841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
